About Lonza 

Following the closing of the Capsugel acquisition, Lonza further strengthened its position as one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

An integrated solutions provider serving the healthcare continuum, Lonza offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. In addition to drinking water sanitizers, nutraceuticals, antidandruff agents and other personal care ingredients, the company provides agricultural products, advanced coatings and composites and microbial control solutions that combat dangerous viruses, bacteria and other pathogens. Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 50 major manufacturing and R&D facilities and nearly 14,000 full-time employees worldwide.



Richard Ridinger Chief Executive Officer
Sven Abend Chief Operating Officer
Marc Funk Chief Operating Officer
Fridtjof Helemann Chief Human Resources Officer 
Rodolfo Savitzky Chief Financial Officer

Major Sites

Amboise (FR) Tuas, Singapore
Alpharetta, GA (USA) Visp, Switzerland
Bend, OR (USA) Kempton Park, Republic of South Africa
Blackley (UK) Nansha, China
Bornem, Belgium Ploërmel, France
Charleston, TN (USA) Portsmouth, NH (USA)
Delhi, India Puebla, Mexico
Greenwood, SC (USA) Sagamihara, Japan
Kouřim, Czech Republic              Salto, Brazil
Porriño, Spain Suzhou, China
Rochester, NY (USA) Walkersville, MD (USA)
Slough, United Kingdom Williamsport, PA (USA)